All Type of News
KCCI urges Health Ministry to push revision bill of pharmaceutical affairs law
The Korea Chamber of Commerce and Industry (KCCI) said Wednesday it delivered a proposal to the Ministry of Health and Welfare calling for propelling a bill to revise the Pharmaceutical Affairs Law, designed to allow ...
Court rejects NHIC’s compensation claim over drugmakers’ improper profit
A local court on Friday dismissed a compensation suit filed by the National Health Insurance Corp. against eight pharmaceutical firms for profiteering about 30 billion won.
The NHIC filed the suit, claiming these c...
Kwangdong announces product licensing agreement with Germany company
Kwangdong Pharmaceutical Co. said recently it entered into a commercial licensing agreement with German Based Engelhard Arzneimittel GmbH on an exclusive basis for distribution of an ivy leaf (photo) extraction produc...
Pfizer Korea is making all-out to go generic drugs
Pfizer Korea is moving into generics in a big way.
The company had quietly been turning out generic versions of some of Pfizer’s own off-patent products for a while, fearing the negative opinions of local pharmaceu...
Korean drugs increase share in gastritis drug market
Korean-made gastritis drugs accounted for a larger portion of the sector's domestic sales last year, an industry report showed recently.
According to Yakup.com, an information company, Dong-A Pharmaceutical's Stil...
Korea's big firms urged to promote pharmaceutical industry
The government unveiled an ambitious vision in 2010 to foster global pharmaceutical firms through the creation of a large-scale R&D fund and offering various tax benefits to local companies.
At that time the Minist...
Drugmakers, government face off over drug price cuts
Tension is escalating between local pharmaceutical firms and the Ministry of Health and Welfare over the government’s plan to slash drug prices.
So far, the local pharmaceutical industry has raised their voice agai...
KPA likely to launch new negotiation team
The Korean Pharmaceutical Association (KPA) is likely to select new members in a special meeting tomorrow in an effort to re-negotiate with the government over controversial agreement to relinquish its monopoly on sal...
KFDA to introduce advance screening system over biopharmaceutical drugs
The Korea Food and Drug Administration plans to introduce an advance screening system, which would help the trial process progress of biopharmaceutical drugs faster.
The drug agency said it will continue its effort...
Anterogen’s stem cell-based anal fistula drug gets green light from KFDA
The Korea Food and Drug Administration said Thursday that it has approved Cupistem, a stem cell-based anal fistula drug by Anterogen Co., a subsidy of Bukwang Pharmaceutical Co.
Anterogen’s Cupistem is a stem cell ...
